Protalix Biotherapeutics (NY: PLX )

1.250 +0.080 (+6.84%)
Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Other Filings

Form SC 13D/A
Source: SEC/Edgar
May 25, 2004
Form 10QSB
Source: SEC/Edgar
May 13, 2004
Form DEFA14A
Source: SEC/Edgar
May 06, 2004
Form 8-K
Source: SEC/Edgar
May 03, 2004
Form DEFA14A
Source: SEC/Edgar
May 03, 2004
Form PRER14A
Source: SEC/Edgar
May 02, 2004
Form SC 13E3/A
Source: SEC/Edgar
May 02, 2004
Form SC 13D/A
Source: SEC/Edgar
April 29, 2004
Form 10-K/A
Source: SEC/Edgar
April 27, 2004
Form 10KSB/A
Source: SEC/Edgar
April 21, 2004
Form DEFA14A
Source: SEC/Edgar
April 18, 2004
Form SC 13D/A
Source: SEC/Edgar
April 18, 2004
Form SC 13D/A
Source: SEC/Edgar
April 14, 2004
Form SC 13D/A
Source: SEC/Edgar
April 13, 2004
Form SC 13D/A
Source: SEC/Edgar
March 24, 2004
Form 425
Source: SEC/Edgar
March 18, 2004
Form SC 13D/A
Source: SEC/Edgar
March 18, 2004
Form DEFA14A
Source: SEC/Edgar
March 15, 2004
Form SC 13D/A
Source: SEC/Edgar
March 08, 2004
Form 425
Source: SEC/Edgar
March 07, 2004
Form 425
Source: SEC/Edgar
March 07, 2004
Form 425
Source: SEC/Edgar
March 07, 2004
Form 425
Source: SEC/Edgar
March 07, 2004
Form 425
Source: SEC/Edgar
March 04, 2004
Form 425
Source: SEC/Edgar
March 04, 2004
Form 8-K
Source: SEC/Edgar
March 02, 2004
Form PREM14A
Source: SEC/Edgar
March 01, 2004
Form SC 13E3
Source: SEC/Edgar
March 01, 2004
Form DEFA14A
Source: SEC/Edgar
February 29, 2004
Form SC 13D/A
Source: SEC/Edgar
February 26, 2004
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.